CORT Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 20.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $7,995,763.33

Corcept Therapeutics Insider Trading History Chart

Corcept Therapeutics Share Price & Price History

^$27.41

▼ -0.12 (-0.44%)

As of 05/14/2024 12:21 PM ET

Days: 30 | 90 | 365

Revolutionizing the Green Energy Space and Building Shareholder Value Along the Way

From Small Cap Sniper | Ad

As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promising companies to be watching closely!

Learn how this American company is leading the lithium-ion revolution

Corcept Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/9/2024	Joseph Douglas Lyon	Insider	Sell	7,227	$26.00	$187,902.00	7,314
5/2/2024	Joseph Douglas Lyon	Insider	Sell	10,830	$26.00	$281,580.00	7,314
4/4/2024	Joseph Douglas Lyon	Insider	Sell	5,443	$26.00	$141,518.00	7,314
4/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$25.30	$55,660.00
4/1/2024	Joseph Douglas Lyon	Insider	Sell	500	$26.01	$13,005.00	7,314
3/27/2024	Sean Maduck	Insider	Sell	25,953	$25.01	$649,084.53	85,222
3/18/2024	Sean Maduck	Insider	Sell	17,219	$25.00	$430,475.00	75,222
3/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$23.59	$51,898.00
2/16/2024	Joseph Douglas Lyon	CAO	Sell	1,000	$26.00	$26,000.00	6,774
2/16/2024	Sean Maduck	Insider	Sell	27,068	$25.97	$702,955.96	74,455
2/1/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$22.00	$48,400.00
1/2/2024	Daniel N. Swisher, Jr.	Director	Sell	2,200	$22.11	$48,642.00
12/22/2023	William Guyer	Insider	Sell	10,000	$32.00	$320,000.00	6,643
12/5/2023	Gary Charles Robb	Insider	Sell	1,381	$26.27	$36,278.87	27,602
12/4/2023	Joseph Douglas Lyon	CAO	Sell	2,432	$26.00	$63,232.00	5,854
12/1/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$25.47	$56,034.00
12/1/2023	Joseph Douglas Lyon	CAO	Sell	2,568	$26.00	$66,768.00	5,854
12/1/2023	Sean Maduck	Insider	Sell	25,000	$25.56	$639,000.00	73,291
11/2/2023	Joseph Douglas Lyon	CAO	Sell	3,977	$28.11	$111,793.47	5,854
11/1/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$27.96	$61,512.00
11/1/2023	Sean Maduck	Insider	Sell	5,112	$28.08	$143,544.96	73,291
10/10/2023	Sean Maduck	Insider	Sell	18,471	$27.29	$504,073.59	73,291
10/6/2023	Joseph Douglas Lyon	CAO	Sell	2,582	$27.24	$70,333.68	5,854
10/6/2023	Sean Maduck	Insider	Sell	3,498	$27.24	$95,285.52	73,610
10/2/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$27.32	$60,104.00
10/2/2023	Joseph Douglas Lyon	CAO	Sell	2,418	$27.25	$65,890.50	5,854
10/2/2023	Sean Maduck	Insider	Sell	3,031	$27.24	$82,564.44	73,610
9/19/2023	Sean Maduck	Insider	Sell	25,000	$32.48	$812,000.00	73,610
9/5/2023	Daniel N. Swisher, Jr.	Director	Sell	2,200	$32.90	$72,380.00
9/1/2023	Daniel N. Swisher, Jr.	Director	Sell	1,550	$32.73	$50,731.50
9/1/2023	Joseph Douglas Lyon	CAO	Sell	5,000	$32.73	$163,650.00	5,132
8/21/2023	Joseph Douglas Lyon	CAO	Sell	4,588	$31.19	$143,099.72	5,132
8/14/2023	David L. Mahoney	Director	Sell	25,000	$30.95	$773,750.00	11,297
8/14/2023	Hazel Hunt	Insider	Sell	20,455	$30.89	$631,854.95	73,146
8/7/2023	Daniel N. Swisher, Jr.	Director	Sell	2,850	$30.14	$85,899.00
8/7/2023	Joseph Douglas Lyon	CAO	Sell	412	$31.22	$12,862.64	4,720
6/6/2023	Joseph Douglas Lyon	CAO	Sell	10,000	$23.60	$236,000.00	5,132
5/9/2023	Gary Charles Robb	Insider	Sell	30,000	$23.87	$716,100.00	33,997
12/1/2022	Sean Maduck	Insider	Sell	625	$25.28	$15,800.00	56,462
11/22/2022	Gary Charles Robb	Insider	Sell	4,814	$26.03	$125,308.42	21,329
11/17/2022	Gary Charles Robb	Insider	Sell	10,000	$26.06	$260,600.00	39,544
11/10/2022	Sean Maduck	Insider	Sell	25,000	$25.57	$639,250.00	56,462
10/3/2022	Sean Maduck	Insider	Sell	25,000	$25.64	$641,000.00	56,462
9/7/2022	Gary Charles Robb	Insider	Sell	50,000	$26.06	$1,303,000.00	49,544
8/9/2022	Sean Maduck	Insider	Sell	200	$28.70	$5,740.00	40,024
7/18/2022	Sean Maduck	Insider	Sell	25,000	$27.37	$684,250.00	40,024
7/6/2022	Gary Charles Robb	Insider	Sell	45,000	$26.00	$1,170,000.00	24,123
7/6/2022	Joseph K. Belanoff	CEO	Sell	279,908	$26.27	$7,353,183.16	2,538,218
5/19/2022	Gary Charles Robb	Insider	Sell	6,127	$19.57	$119,905.39	36,446
5/17/2022	Gary Charles Robb	Insider	Sell	28,745	$19.55	$561,964.75	42,701
3/17/2022	Gary Charles Robb	Insider	Sell	7,512	$24.68	$185,396.16
10/5/2021	Sean Maduck	Insider	Sell	637	$20.00	$12,740.00
10/1/2021	Sean Maduck	Insider	Sell	24,363	$20.00	$487,260.00
9/15/2021	Gary Charles Robb	Insider	Sell	47,853	$20.49	$980,507.97
9/13/2021	Gary Charles Robb	Insider	Sell	6,341	$20.89	$132,463.49	136,507
9/2/2021	Daniel N. Swisher, Jr.	Director	Sell	7,500	$21.70	$162,750.00	7,500
9/1/2021	Sean Maduck	Insider	Sell	25,000	$21.40	$535,000.00	65,024
8/3/2021	Sean Maduck	Insider	Sell	25,000	$21.18	$529,500.00	65,024
7/7/2021	Sean Maduck	Insider	Sell	25,000	$22.19	$554,750.00
6/11/2021	G. Leonard Baker, Jr.	Director	Buy	50,000	$21.53	$1,076,500.00
6/2/2021	Daniel N. Swisher, Jr.	Director	Sell	7,500	$21.48	$161,100.00	7,500

Guard Against the Coming Financial Upheaval

From Porter & Company | Ad

America’s Most Shocking Financial Story… Behind closed doors in D.C., there is a dark political and economic plot underway. That’s why if you have any savings in the bank or own any assets you want to protect, you must watch this new documentary before it’s too late.

You can stream it for free right here.

SEC Filings (Institutional Ownership Changes) for Corcept Therapeutics (NASDAQ:CORT)

93.61% of Corcept Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Corcept Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/14/2024	CANADA LIFE ASSURANCE Co	78,987	$1.99M	0.0%	-14.1%	0.076%
5/13/2024	UniSuper Management Pty Ltd	17,536	$0.44M	0.0%	N/A	0.017%
5/13/2024	Clearbridge Investments LLC	582,355	$14.67M	0.0%	N/A	0.559%
5/13/2024	O Shaughnessy Asset Management LLC	8,344	$0.21M	0.0%	+27.7%	0.008%
5/11/2024	Covestor Ltd	5,009	$0.13M	0.1%	+32.1%	0.005%
5/11/2024	Edgestream Partners L.P.	60,291	$1.52M	0.1%	N/A	0.058%
5/10/2024	Acadian Asset Management LLC	236,199	$5.94M	0.0%	-13.7%	0.227%
5/10/2024	Vanguard Group Inc.	9,565,782	$240.96M	0.0%	+0.3%	9.188%
5/10/2024	Jupiter Asset Management Ltd.	744,469	$18.75M	0.2%	+1,149.0%	0.715%
5/9/2024	State Board of Administration of Florida Retirement System	66,866	$1.68M	0.0%	+190.0%	0.064%
5/8/2024	ProShare Advisors LLC	16,617	$0.42M	0.0%	+8.7%	0.016%
5/8/2024	US Bancorp DE	25,282	$0.64M	0.0%	+6,252.3%	0.024%
5/8/2024	Russell Investments Group Ltd.	108,977	$2.75M	0.0%	+464.0%	0.105%
5/8/2024	QRG Capital Management Inc.	74,620	$1.88M	0.0%	-5.9%	0.072%
5/7/2024	Sei Investments Co.	61,627	$1.55M	0.0%	+207.7%	0.059%
5/7/2024	Susquehanna Fundamental Investments LLC	14,740	$0.37M	0.0%	N/A	0.014%
5/7/2024	KCM Investment Advisors LLC	57,226	$1.44M	0.1%	+7.6%	0.055%
5/7/2024	Swiss National Bank	172,965	$4.36M	0.0%	+0.7%	0.166%
5/7/2024	Illinois Municipal Retirement Fund	52,460	$1.32M	0.0%	+5.2%	0.050%
5/7/2024	SG Americas Securities LLC	6,831	$0.17M	0.0%	-96.8%	0.007%
5/6/2024	Quantbot Technologies LP	14,405	$0.36M	0.0%	-65.6%	0.014%
5/6/2024	Duality Advisers LP	89,188	$2.25M	0.2%	+653.1%	0.086%
5/6/2024	Texas Permanent School Fund Corp	79,390	$2M	0.0%	+1.8%	0.076%
5/3/2024	GSA Capital Partners LLP	30,315	$0.76M	0.1%	-26.4%	0.029%
5/2/2024	Mutual of America Capital Management LLC	135,102	$3.40M	0.0%	-6.8%	0.130%
5/2/2024	FinTrust Capital Advisors LLC	1,771	$45K	0.0%	+318.7%	0.002%
5/2/2024	Hussman Strategic Advisors Inc.	84,000	$2.12M	0.5%	+60.0%	0.081%
5/1/2024	Janney Montgomery Scott LLC	28,010	$0.71M	0.0%	N/A	0.027%
5/1/2024	BNP Paribas Financial Markets	211,592	$5.33M	0.0%	+199.0%	0.203%
4/30/2024	Norden Group LLC	116,850	$2.94M	0.2%	N/A	0.112%
4/30/2024	Arkadios Wealth Advisors	17,227	$0.43M	0.0%	N/A	0.017%
4/29/2024	Commonwealth Equity Services LLC	191,577	$4.83M	0.0%	N/A	0.184%
4/29/2024	FAS Wealth Partners Inc.	311,383	$7.84M	0.7%	+0.4%	0.299%
4/29/2024	Principal Financial Group Inc.	526,138	$13.25M	0.0%	+5.3%	0.506%
4/29/2024	Meritage Portfolio Management	24,450	$0.62M	0.0%	-6.9%	0.023%
4/26/2024	Yousif Capital Management LLC	33,295	$0.84M	0.0%	-9.9%	0.032%
4/25/2024	Cambridge Investment Research Advisors Inc.	324,271	$8.17M	0.0%	+2,922.7%	0.312%
4/23/2024	Milestone Asset Management LLC	35,006	$0.88M	0.3%	N/A	0.034%
4/23/2024	Raymond James Financial Services Advisors Inc.	50,105	$1.26M	0.0%	N/A	0.048%
4/19/2024	Norden Group LLC	1,988,133	$50.08M	0.5%	N/A	1.921%
4/18/2024	Allspring Global Investments Holdings LLC	126,807	$3.19M	0.0%	+85.6%	0.122%
4/18/2024	AlphaMark Advisors LLC	9,375	$0.24M	0.1%	N/A	0.009%
4/17/2024	Hennion & Walsh Asset Management Inc.	54,869	$1.38M	0.1%	+38.8%	0.053%
4/15/2024	Sound Income Strategies LLC	4,959	$0.13M	0.0%	N/A	0.005%
4/13/2024	Evanson Asset Management LLC	23,444	$0.59M	0.0%	-24.4%	0.023%
4/10/2024	Clearview Wealth Advisors LLC	14,382	$0.36M	0.4%	N/A	0.014%
4/5/2024	GAMMA Investing LLC	1,218	$31K	0.0%	+90.6%	0.001%
4/5/2024	Los Angeles Capital Management LLC	48,819	$1.23M	0.0%	-2.8%	0.047%
3/22/2024	PNC Financial Services Group Inc.	11,008	$0.36M	0.0%	+28.4%	0.011%
3/11/2024	Vanguard Group Inc.	9,537,532	$309.78M	0.0%	+2.6%	9.213%
3/1/2024	Goldman Sachs Group Inc.	532,760	$17.30M	0.0%	+30.4%	0.515%
2/23/2024	Cim LLC	15,650	$0.51M	0.1%	N/A	0.015%
2/14/2024	Intrinsic Edge Capital Management LLC	466,876	$15.16M	1.5%	N/A	0.453%
2/13/2024	Quantedge Capital Pte Ltd	248,342	$8.07M	3.9%	N/A	0.241%
2/13/2024	Campbell & CO Investment Adviser LLC	32,578	$1.06M	0.1%	+224.8%	0.032%
2/12/2024	Allianz Asset Management GmbH	48,818	$1.59M	0.0%	+50.7%	0.047%
2/12/2024	Parallel Advisors LLC	3,768,245	$122.39M	3.6%	+1.2%	3.656%
2/12/2024	Hsbc Holdings PLC	46,429	$1.51M	0.0%	+78.1%	0.045%
2/9/2024	Franklin Resources Inc.	227,585	$7.39M	0.0%	+2.0%	0.221%
2/9/2024	Assetmark Inc.	56,101	$1.82M	0.0%	+221.9%	0.054%
2/9/2024	Quest Partners LLC	8,547	$0.28M	0.1%	N/A	0.008%
2/9/2024	Trexquant Investment LP	60,518	$1.97M	0.0%	-20.1%	0.059%
2/9/2024	PNC Financial Services Group Inc.	11,008	$0.36M	0.0%	+28.4%	0.011%
2/9/2024	BI Asset Management Fondsmaeglerselskab A S	12,851	$0.42M	0.0%	+17.7%	0.012%
2/9/2024	Norges Bank	757,490	$24.60M	0.0%	N/A	0.735%
2/8/2024	Robeco Institutional Asset Management B.V.	28,230	$0.92M	0.0%	+38.0%	0.027%
2/8/2024	Verity Asset Management Inc.	7,211	$0.23M	0.1%	N/A	0.007%
2/8/2024	Great Lakes Advisors LLC	335,895	$10.91M	0.1%	-1.6%	0.326%
2/8/2024	Quadrant Capital Group LLC	2,107	$68K	0.0%	+27.0%	0.002%
2/8/2024	Vanguard Personalized Indexing Management LLC	7,013	$0.23M	0.0%	N/A	0.007%
2/7/2024	Principal Financial Group Inc.	499,686	$16.23M	0.0%	-1.0%	0.485%
2/7/2024	Dimensional Fund Advisors LP	2,310,297	$75.04M	0.0%	+0.1%	2.241%
2/7/2024	QRG Capital Management Inc.	79,263	$2.57M	0.0%	+10.2%	0.077%
2/7/2024	Jump Financial LLC	49,226	$1.60M	0.1%	N/A	0.048%
2/7/2024	BNP Paribas Financial Markets	70,777	$2.30M	0.0%	-22.7%	0.069%
2/7/2024	Teacher Retirement System of Texas	20,137	$0.65M	0.0%	-17.9%	0.020%
2/7/2024	Versor Investments LP	37,378	$1.21M	0.2%	+63.8%	0.036%
2/7/2024	Gladius Capital Management LP	1,098	$36K	0.0%	N/A	0.001%
2/6/2024	Charles Schwab Investment Management Inc.	900,444	$29.25M	0.0%	+4.5%	0.874%
2/6/2024	Amalgamated Bank	37,138	$1.21M	0.0%	-3.6%	0.036%
2/6/2024	Los Angeles Capital Management LLC	50,219	$1.63M	0.0%	-15.3%	0.049%
2/6/2024	Natixis Advisors L.P.	21,907	$0.71M	0.0%	-7.9%	0.021%
2/6/2024	Swiss National Bank	171,765	$5.58M	0.0%	-9.5%	0.167%
2/5/2024	Victory Capital Management Inc.	46,731	$1.52M	0.0%	-40.9%	0.045%
2/5/2024	Jackson Creek Investment Advisors LLC	34,163	$1.11M	0.4%	N/A	0.033%
2/5/2024	Convergence Investment Partners LLC	10,982	$0.36M	0.2%	N/A	0.011%
2/5/2024	Russell Investments Group Ltd.	19,322	$0.64M	0.0%	-10.4%	0.019%
2/2/2024	Headlands Technologies LLC	1,452	$47K	0.0%	N/A	0.001%
2/2/2024	Truist Financial Corp	14,753	$0.48M	0.0%	-20.4%	0.014%
2/2/2024	State of New Jersey Common Pension Fund D	98,330	$3.19M	0.0%	+29.4%	0.095%
2/2/2024	Meritage Portfolio Management	26,268	$0.85M	0.1%	+3.7%	0.025%
2/1/2024	Yousif Capital Management LLC	36,950	$1.20M	0.0%	-6.5%	0.036%
2/1/2024	Linden Thomas Advisory Services LLC	56,671	$1.84M	0.3%	+1.0%	0.055%
2/1/2024	New York State Common Retirement Fund	70,235	$2.28M	0.0%	-34.3%	0.068%
2/1/2024	Illinois Municipal Retirement Fund	49,852	$1.62M	0.0%	-7.0%	0.048%
2/1/2024	Hussman Strategic Advisors Inc.	52,500	$1.71M	0.4%	-16.7%	0.051%
1/31/2024	Cornerstone Investment Partners LLC	6,233	$0.20M	0.0%	N/A	0.006%
1/31/2024	Federated Hermes Inc.	1,689,729	$54.88M	0.1%	-0.1%	1.639%
1/30/2024	Zurcher Kantonalbank Zurich Cantonalbank	20,756	$0.67M	0.0%	+51.3%	0.020%
1/30/2024	Mackenzie Financial Corp	6,448	$0.21M	0.0%	N/A	0.006%

Data available starting January 2016

Corcept Therapeutics Incorporated engages in discovery and development of drugs for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States. It offers Korlym tablets medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous cushing's syndrome; and who have type 2 diabetes mellitus or glucose intolerance and have failed surgery or are not candidates for surgery. The company is also developing relacorilant, which is in phase III clinical trial for the treatment of cushing's syndrome; treatment for adrenal cancer and cortisol excess which is in phase 1b clinical trial; treatment for prostate cancer which is in phase II clinical trial; and nab-paclitaxel in combination with relacorilant, which is in phase III clinical trial to treat platinum-resistant ovarian tumors. In addition, it develops dazucorilant, which is in phase II clinical trial for the treatment of amyotrophic lateral sclerosis; miricorilant, which is in phase IIb trial for the treatment of nonalcoholic steatohepatitis; and treatment for antipsychotic induced weight gain that is in phase I trial. The company was incorporated in 1998 and is headquartered in Menlo Park, California.

Today's Range

Now: $27.41

$26.87

$28.18

50 Day Range

MA: $24.22

$22.21

$27.53

52 Week Range

Now: $27.41

$20.84

$34.28

Volume

241,350 shs

Average Volume

1,448,217 shs

Market Capitalization

$2.85 billion

P/E Ratio

25.86

Dividend Yield

N/A

Beta

0.5

Who are the company insiders with the largest holdings of Corcept Therapeutics?: Corcept Therapeutics' top insider investors include:
Joseph K Belanoff (CEO)
Sean Maduck (Insider)
Hazel Hunt (Insider)
Gary Charles Robb (Insider)
David L Mahoney (Director)
Joseph Douglas Lyon (Insider)
Joseph Douglas Lyon (CAO)
William Guyer (Insider)
Daniel N Swisher, Jr (Director)
Learn More about top insider investors at Corcept Therapeutics.
Who are the major institutional investors of Corcept Therapeutics?: Corcept Therapeutics' top institutional shareholders include:
Vanguard Group Inc. — 9.19%
Norden Group LLC — 1.92%
Jupiter Asset Management Ltd. — 0.72%
Clearbridge Investments LLC — 0.56%
Principal Financial Group Inc. — 0.51%
Cambridge Investment Research Advisors Inc. — 0.31%
Learn More about top institutional investors of Corcept Therapeutics stock.
Which institutional investors are selling Corcept Therapeutics stock?: During the last quarter, CORT stock was sold by these institutional investors:
SG Americas Securities LLC
Acadian Asset Management LLC
Quantbot Technologies LP
CANADA LIFE ASSURANCE Co
GSA Capital Partners LLP
Mutual of America Capital Management LLC
Evanson Asset Management LLC
QRG Capital Management Inc.
During the previous year, company insiders that have sold Corcept Therapeutics company stock include:
Joseph K Belanoff (CEO)
Sean Maduck (Insider)
Hazel Hunt (Insider)
Gary Charles Robb (Insider)
David L Mahoney (Director)
Joseph Douglas Lyon (Insider)
Joseph Douglas Lyon (CAO)
William Guyer (Insider)
Learn More investors selling Corcept Therapeutics stock.
Which institutional investors are buying Corcept Therapeutics stock?: In the previous quarter, CORT stock was bought by institutional investors including:
Norden Group LLC
Jupiter Asset Management Ltd.
Clearbridge Investments LLC
Cambridge Investment Research Advisors Inc.
Commonwealth Equity Services LLC
BNP Paribas Financial Markets
Norden Group LLC
Russell Investments Group Ltd.